In addition to modest cost synergies expectations ($275 million) that Moody's views as achievable, the broader portfolio and revenue base over which the company will be able to leverage research and development spending, should improve profit margins and cash flow from already strong levels.The stable outlook reflects Moody's expectations that Maxim will maintain its competitive positions throughout its high performance analog portfolio and continue to generate solid operating profits and free cash flow through cycles.